Chairs: Anna DeFazio AM & John Lock
INVITED SPEAKERS: HUBERT HONDERMARK & HELEN RIZOS
Cancer Neuroscience: a New Frontier in Oncology (#32)
11:15 AM
Lessons from a decade of immune checkpoint inhibitors (#33)
11:35 AM
Identification of differential DNA methylation in phyllodes tumours establishes a signature of malignancy and delineates from metaplastic breast carcinoma (#34)
11:55 AM
Putting the brakes on CDK4/6 inhibitor resistance in estrogen receptor positive breast cancers by harnessing the potential of CDK1 inhibition (#35)
12:05 PM
More mutational sources underlying kataegis in African prostate cancer (#36)
12:15 PM
βIII-Tubulin knockdown sensitises pancreatic tumours to the tumour-specific death ligand TRAIL. (#37)
12:25 PM
Inhibition of the NPY signalling axis as a novel therapeutic option in Pancreatic Cancer. (#38)
12:35 PM
Using copper chelation to target epigenetic and kinase signalling influence of cell cycle in DIPG (#39)
12:45 PM